Issue : The Pharmaceutical Journal, May, Vol 298, No 7901
Sort by: Newest first Oldest first A-Z Z-A
-
Cancer drugs fund did not provide meaningful value to patients, say researchers
The NHS Cancer Drugs Fund (CDF) has not provided meaningful value to cancer patients and wider society and may have unnecessarily exposed patients to adverse drug reactions, according to a study published in the Annals of Oncology.
-
MP group wants pharmacist prescribers and minor ailment scheme in England
All-party parliamentary group recommends community pharmacy play a bigger role in the NHS to take pressure off GPs.
-
RPS board members must champion our aspirations Subscription
The Royal Pharmaceutical Society (RPS) may struggle to engage its membership, particularly those early in their careers. To find solutions, it is natural to look to the elder statesmen of the profession. However, the next generation of pharmacists are watching this RPS election with a keen eye. Although I have no vote, I hope to see board members elected who will take account of our aspirations and expectations. Undoubtedly, the profession and the Society face mounting challenges and ...
-
An NHS surgeon’s retrospective look at his career Subscription
Tender is the scalpel’s edge, by Gautam Das.
-
Pharmaceutical industry urges European Council to decide new site for EMA
The pharmaceutical industry is urging the European Council to make a decision on the location of the new headquarters of the European Medicines Agency (EMA), preferably by June 2017, because of the potential “alarming” impact Brexit could have on medicines regulation.
-
FDA restricts use of codeine and tramadol in children
The US drug regulator has issued restrictions on codeine and tramadol in children’s medicines.
-
New revalidation plans spelled out for pharmacy professionals by regulator
Pharmacists and pharmacy technicians will see the number of activities they have to undertake for continuing professional development fall from nine to six as part of new plans.
-
Anti-epileptic drug valproate linked to around 4,000 birth defects in France
Women who took the drug in pregnancy were four times more likely than women in the general population to give birth to babies with severe congenital malformations.
-
Setting up a pharmacy provider company to win tenders for new services
With public health bodies and clinical commissioning groups now seeking single organisations to manage local services, Steve Hemsley examines the benefits for community pharmacists and pharmacies when creating pharmacy provider companies to tender for new services, as well as the risks and challenges posed by this new approach.
-
Randomised trial confirms efficacy of apomorphine for advanced Parkinson’s
A drug first produced in 1865 offers relief for people with advanced Parkinson’s disease, study confirms.
Show 10 per page20 per page50 per page
